Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Etoricoxib
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Etoricoxib 60mg tablets
1001010AJAAAAAA
|
Etoricoxib | Etoricoxib | Musculoskeletal and Joint Diseases | 62,759 |
|
Etoricoxib 90mg tablets
1001010AJAAABAB
|
Etoricoxib | Etoricoxib | Musculoskeletal and Joint Diseases | 45,111 |
|
Etoricoxib 30mg tablets
1001010AJAAADAD
|
Etoricoxib | Etoricoxib | Musculoskeletal and Joint Diseases | 22,128 |
|
Etoricoxib 120mg tablets
1001010AJAAACAC
|
Etoricoxib | Etoricoxib | Musculoskeletal and Joint Diseases | 6,697 |
|
Arcoxia 90mg tablets
1001010AJBBABAB
|
Arcoxia | Etoricoxib | Musculoskeletal and Joint Diseases | 1,527 |
|
Arcoxia 60mg tablets
1001010AJBBAAAA
|
Arcoxia | Etoricoxib | Musculoskeletal and Joint Diseases | 1,351 |
|
Arcoxia 30mg tablets
1001010AJBBADAD
|
Arcoxia | Etoricoxib | Musculoskeletal and Joint Diseases | 556 |
|
Arcoxia 120mg tablets
1001010AJBBACAC
|
Arcoxia | Etoricoxib | Musculoskeletal and Joint Diseases | 257 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.